(Reuters) - Gene therapy maker Bluebird bio said on Friday it would be taken private by Carlyle and SK Capital Partners, ...

BNP Paribas's stake increase in Ageas to more than 15% is boosting the insurer's shares, making it the best performer of Belgium's blue-chip index. Shares in Ageas rose more than 3% in morning trading ...

Trump administration orders and directives have some in the construction sector optimistic, but actions are disrupting government functions with impacts feared for industry operations, costs and risks ...